Trial Profile
A phase II, randomised trial of Azixa in combination with temozolomide in patients with metastatic melanoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2014
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Verubulin (Primary)
- Indications Cancer metastases; Malignant melanoma
- Focus Therapeutic Use
- 23 Jun 2014 Planned number of patients changed to 450.
- 23 Jun 2014 Planned number of patients changed from 450 to NULL.
- 10 Nov 2010 Status changed from recruiting to completed, according to an EpiCept media release.